COVID-19: WHO Decides To Resume Clinical Trials For Anti-malaria Drug Hydroxychloroquine

Anti-malaria drug hydroxychloroquine will be once again tested for its effectiveness against the novel coronavirus as the World Health Organization has decided to resume its trials under the Solidarity Trials. last week, the WHO had suspended the trials for hydroxychloroquine as concerns were raised about the safety of the drug.

Subscribe to India Today for NEW VIDEOS EVERY DAY and make sure to enable Push Notifications so you'll never miss a new video.
All you need to do is PRESS THE BELL ICON next to the Subscribe button!

India Today TV is India's leading English News Channel. India Today YouTube channel offers latest news videos on Politics, Business, Cricket, Bollywood, Lifestyle, Auto, Technology, Travel, Entertainment and a lot more.

Stay tuned for latest updates and in-depth analysis of news from India and around the world!

Download Mobile App from India’s No.1 News Video Publisher :

Follow us: Official website:

Twitter:

Facebook:

who,who to resume hcq study,who hcq trials to resmue,who on hcq trials,who hcq study,hcq trials,hcq,who solidarity trials,hydroxychloroquine coronavirus trials to resume,who on hcq,coronavirus : hydroxychloroquine clinical trials will resume,covid trials,trial,hcq study,hcq for treating covid,who us president,who on covid 19,